Elhan Webb
Investor Relations Contact chez KARYOPHARM THERAPEUTICS INC.
Postes actifs de Elhan Webb
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Investor Relations Contact | 14/03/2022 | - |
Historique de carrière de Elhan Webb
Anciens postes connus de Elhan Webb
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ROCHE HOLDING AG | Public Communications Contact | - | - |
| RUBIUS THERAPEUTICS | Investor Relations Contact | 01/11/2020 | - |
| RADIUS HEALTH, INC. | Investor Relations Contact | 02/01/2018 | - |
| Public Communications Contact | 02/01/2018 | - |
Formation de Elhan Webb
| University of Southern California | Masters Business Admin |
| Bogazici University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Suisse | 2 |
| Turquie | 2 |
Opérationnelle
| Investor Relations Contact | 3 |
| Public Communications Contact | 2 |
| Masters Business Admin | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
- Bourse
- Insiders
- Elhan Webb
- Expérience
